Practice guidelines for pharmacists: The management of osteoarthritis.
作者信息
Kielly Jason, Davis Erin M, Marra Carlo
机构信息
School of Pharmacy (Kielly, Davis) and the Faculty of Medicine (Davis), Memorial University, St. John's, Newfoundland; and the National School of Pharmacy (Marra), University of Otago, Dunedin, New Zealand.
出版信息
Can Pharm J (Ott). 2017 May 1;150(3):156-168. doi: 10.1177/1715163517702168. eCollection 2017 May-Jun.
Abstract
摘要
相似文献
1
Practice guidelines for pharmacists: The management of osteoarthritis.药剂师实践指南：骨关节炎的管理
Can Pharm J (Ott). 2017 May 1;150(3):156-168. doi: 10.1177/1715163517702168. eCollection 2017 May-Jun.
2
Evaluation of a complex intervention for changing professional behaviour: the Evidence Based Out Reach (EBOR) Trial.一项关于改变专业行为的复杂干预措施的评估：循证外展（EBOR）试验
J Health Serv Res Policy. 2002 Oct;7(4):230-8. doi: 10.1258/135581902320432769.
3
Osteoarthritis guidelines take balanced approach to therapy.骨关节炎指南对治疗采取平衡的方法。
Am J Health Syst Pharm. 2012 Jun 1;69(11):906, 908. doi: 10.2146/news120038.
4
Implementing Evidence-Based Guidelines: The Role of Ambulatory Care Pharmacists.实施循证指南：门诊护理药师的作用。
N C Med J. 2015 Sep-Oct;76(4):247-50. doi: 10.18043/ncm.76.4.247.
5
Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies.荷兰社区药房对国家药物相互作用管理指南的遵循情况。
Ann Pharmacother. 2007 Dec;41(12):2024-31. doi: 10.1345/aph.1K240. Epub 2007 Oct 30.
6
Migraine management in community pharmacies: practice patterns and knowledge of pharmacy personnel in Thailand.社区药店的偏头痛管理：泰国药店人员的实践模式和知识。
Headache. 2013 Oct;53(9):1451-63. doi: 10.1111/head.12163. Epub 2013 Jun 28.
7
Cholesterol management in geriatric patients: new guidelines.老年患者的胆固醇管理：新指南
Consult Pharm. 2015 Feb;30(2):68-76. doi: 10.4140/TCP.n.2015.68.
8
Hospital pharmacists' awareness of a new antibiotic guideline in the UK: implications for practice.英国医院药剂师对一项新抗生素指南的认知：对实践的影响。
Pharm World Sci. 2005 Jun;27(3):215-9. doi: 10.1007/s11096-004-1734-1.
9
A systematic review and evidence synthesis of qualitative studies to identify primary care clinicians' barriers and enablers to the management of osteoarthritis.一项定性研究的系统评价与证据综合，以确定初级保健临床医生在骨关节炎管理方面的障碍和促进因素。
Osteoarthritis Cartilage. 2017 May;25(5):625-638. doi: 10.1016/j.joca.2016.12.002. Epub 2016 Dec 7.
10
Challenges in the management of chronic noncommunicable diseases by Indonesian community pharmacists.印度尼西亚社区药剂师在慢性非传染性疾病管理方面面临的挑战。
Pharm Pract (Granada). 2015 Apr-Jun;13(3):578. doi: 10.18549/PharmPract.2015.03.578. Epub 2015 Jun 15.
引用本文的文献
1
Pharmacist-Driven Chondroprotection in Osteoarthritis: A Multifaceted Approach Using Patient Education, Information Visualization, and Lifestyle Integration.药剂师主导的骨关节炎软骨保护：一种采用患者教育、信息可视化和生活方式整合的多方面方法。
Pharmacy (Basel). 2025 Aug 1;13(4):106. doi: 10.3390/pharmacy13040106.
2
Reporting form and content of research priorities identified in knee osteoarthritis clinical practice guidelines: a methodological literature analysis.研究重点报告形式和内容在骨关节炎临床实践指南中确定：方法学文献分析。
BMJ Open. 2024 Apr 10;14(4):e076107. doi: 10.1136/bmjopen-2023-076107.
3
Mechanism of icariin for the treatment of osteoarthritis based on network pharmacology and molecular docking method.基于网络药理学和分子对接方法的淫羊藿苷治疗骨关节炎的机制
Am J Transl Res. 2023 Aug 15;15(8):5071-5084. eCollection 2023.
4
Osteoarthritis management: Does the pharmacist play a role in bridging the gap between what patients actually know and what they ought to know? Insights from a national online survey.骨关节炎管理：药剂师在缩小患者实际了解和应了解之间的差距方面是否发挥作用？来自全国在线调查的见解。
Health Expect. 2022 Jun;25(3):936-946. doi: 10.1111/hex.13429. Epub 2022 Jan 8.
5
Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition).《中国骨关节炎诊疗指南（2019年版）》
Ann Transl Med. 2020 Oct;8(19):1213. doi: 10.21037/atm-20-4665.
6
Acupuncture reduces pain in rats with osteoarthritis by inhibiting MCP2/CCR2 signaling pathway.针灸通过抑制 MCP2/CCR2 信号通路减轻骨关节炎大鼠的疼痛。
Exp Biol Med (Maywood). 2020 Dec;245(18):1722-1731. doi: 10.1177/1535370220952342. Epub 2020 Sep 2.
7
Efficacy of Piroxicam Mesotherapy in Treatment of Knee Osteoarthritis: A Randomized Clinical Trial.吡罗昔康中胚层疗法治疗膝骨关节炎的疗效：一项随机临床试验。
Evid Based Complement Alternat Med. 2020 Aug 1;2020:6940741. doi: 10.1155/2020/6940741. eCollection 2020.
8
Therapeutic Effectiveness and Safety of Mesotherapy in Patients with Osteoarthritis of the Knee.中胚层疗法治疗膝骨关节炎患者的疗效与安全性
Evid Based Complement Alternat Med. 2018 Jan 4;2018:6513049. doi: 10.1155/2018/6513049. eCollection 2018.
本文引用的文献
1
Projecting the direct cost burden of osteoarthritis in Canada using a microsimulation model.使用微观模拟模型预测加拿大骨关节炎的直接成本负担。
Osteoarthritis Cartilage. 2015 Oct;23(10):1654-63. doi: 10.1016/j.joca.2015.05.029. Epub 2015 Jun 5.
2
Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies.个体非甾体抗炎药与急性肾损伤风险：观察性研究的系统评价和荟萃分析。
Eur J Intern Med. 2015 May;26(4):285-91. doi: 10.1016/j.ejim.2015.03.008. Epub 2015 Apr 8.
3
Efficacy and safety of paracetamol for spinal pain and osteoarthritis: systematic review and meta-analysis of randomised placebo controlled trials.对乙酰氨基酚治疗脊柱疼痛和骨关节炎的疗效与安全性：随机安慰剂对照试验的系统评价与荟萃分析
BMJ. 2015 Mar 31;350:h1225. doi: 10.1136/bmj.h1225.
4
Transcutaneous Electrical Nerve Stimulation in Patients With Knee Osteoarthritis: Evidence From Randomized-controlled Trials.膝骨关节炎患者的经皮电神经刺激：来自随机对照试验的证据。
Clin J Pain. 2016 Feb;32(2):146-54. doi: 10.1097/AJP.0000000000000233.
5
Comparative effectiveness of pharmacologic interventions for knee osteoarthritis: a systematic review and network meta-analysis.药物干预治疗膝骨关节炎的疗效比较：系统评价和网络荟萃分析。
Ann Intern Med. 2015 Jan 6;162(1):46-54. doi: 10.7326/M14-1231.
6
Nonsteroidal antiinflammatory drugs, cyclooxygenase-2, and the kidneys.非甾体抗炎药、环氧化酶-2与肾脏
Prim Care. 2014 Dec;41(4):803-21. doi: 10.1016/j.pop.2014.09.001. Epub 2014 Nov 4.
7
Capsaicin for osteoarthritis pain.辣椒素治疗骨关节炎疼痛。
Prog Drug Res. 2014;68:277-91. doi: 10.1007/978-3-0348-0828-6_11.
8
OARSI guidelines for the non-surgical management of knee osteoarthritis.美国骨与软组织放射学会膝关节骨关节炎非手术治疗指南
Osteoarthritis Cartilage. 2014 Mar;22(3):363-88. doi: 10.1016/j.joca.2014.01.003. Epub 2014 Jan 24.
9
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.非甾体抗炎药的血管和上消化道作用：来自随机试验的个体参与者数据的荟萃分析。
Lancet. 2013 Aug 31;382(9894):769-79. doi: 10.1016/S0140-6736(13)60900-9. Epub 2013 May 30.
10
Pharmacist-initiated intervention trial in osteoarthritis: a multidisciplinary intervention for knee osteoarthritis.药师主导的干预试验治疗骨关节炎：膝关节骨关节炎的多学科干预。
Arthritis Care Res (Hoboken). 2012 Dec;64(12):1837-45. doi: 10.1002/acr.21763.
Zotero 插件